These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 33162389)
1. Subclinical atheromatosis localization and burden in a low-to-moderate cardiovascular risk population: the ILERVAS study. Bermúdez-López M; Martínez-Alonso M; Castro-Boqué E; Betriu À; Cambray S; Farràs C; Barbé F; Pamplona R; Lecube A; Mauricio D; Purroy F; Valdivielso JM; Fernández E; Rev Esp Cardiol (Engl Ed); 2021 Dec; 74(12):1042-1053. PubMed ID: 33162389 [TBL] [Abstract][Full Text] [Related]
2. Characteristics of atheromatosis in the prediabetes stage: a cross-sectional investigation of the ILERVAS project. Sánchez E; Betriu À; López-Cano C; Hernández M; Fernández E; Purroy F; Bermúdez-López M; Farràs-Sallés C; Barril S; Pamplona R; Rius F; Hernández C; Simó R; Lecube A; Cardiovasc Diabetol; 2019 Nov; 18(1):154. PubMed ID: 31729979 [TBL] [Abstract][Full Text] [Related]
3. Cumulative tobacco consumption has a dose-dependent effect on atheromatosis burden and improves severe atheromatosis prediction in asymptomatic middle-aged individuals: The ILERVAS study. Bermúdez-López M; Martí-Antonio M; Castro-Boqué E; Bretones MDM; Farràs C; Gonzalez J; Pamplona R; Lecube A; Mauricio D; Cambray S; Valdivielso JM; Fernández E; Atherosclerosis; 2023 Jun; 375():75-83. PubMed ID: 37276714 [TBL] [Abstract][Full Text] [Related]
4. Predictors of Subclinical Atheromatosis Progression over 2 Years in Patients with Different Stages of CKD. Gracia M; Betriu À; Martínez-Alonso M; Arroyo D; Abajo M; Fernández E; Valdivielso JM; Clin J Am Soc Nephrol; 2016 Feb; 11(2):287-96. PubMed ID: 26668022 [TBL] [Abstract][Full Text] [Related]
5. Are Obesity Indices Useful for Detecting Subclinical Atheromatosis in a Middle-Aged Population? Sánchez E; Sánchez M; Betriu À; Rius F; Torres G; Purroy F; Pamplona R; Ortega M; López-Cano C; Hernández M; Bueno M; Fernández E; Salvador J; Lecube A; Obes Facts; 2020; 13(1):29-39. PubMed ID: 31968341 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and Burden of Carotid and Femoral Atherosclerosis in Subjects Without Known Cardiovascular Disease in a Large Community Hospital in South-America. Botto F; Obregon S; Forcada P; Di Leva A; Fischer Sohn G; Bang JH; Koretzky M; Baratta S; Kotliar C High Blood Press Cardiovasc Prev; 2024 Mar; 31(2):177-187. PubMed ID: 38436891 [TBL] [Abstract][Full Text] [Related]
7. Factors predicting cardiovascular events in chronic kidney disease patients. Role of subclinical atheromatosis extent assessed by vascular ultrasound. Valdivielso JM; Betriu A; Martinez-Alonso M; Arroyo D; Bermudez-Lopez M; Fernandez E; PLoS One; 2017; 12(10):e0186665. PubMed ID: 29045466 [TBL] [Abstract][Full Text] [Related]
8. The Additive Value of Femoral Ultrasound for Subclinical Atherosclerosis Assessment in a Single Center Cohort of 962 Adults, Including High Risk Patients with Rheumatoid Arthritis, Human Immunodeficiency Virus Infection and Type 2 Diabetes Mellitus. Protogerou AD; Fransen J; Zampeli E; Argyris AA; Aissopou E; Arida A; Konstantonis GD; Tentolouris N; Makrilakis K; Psichogiou M; Daikos G; Kitas GD; Sfikakis PP PLoS One; 2015; 10(7):e0132307. PubMed ID: 26230728 [TBL] [Abstract][Full Text] [Related]
9. Prevalence, Vascular Distribution, and Multiterritorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort: The PESA (Progression of Early Subclinical Atherosclerosis) Study. Fernández-Friera L; Peñalvo JL; Fernández-Ortiz A; Ibañez B; López-Melgar B; Laclaustra M; Oliva B; Mocoroa A; Mendiguren J; Martínez de Vega V; García L; Molina J; Sánchez-González J; Guzmán G; Alonso-Farto JC; Guallar E; Civeira F; Sillesen H; Pocock S; Ordovás JM; Sanz G; Jiménez-Borreguero LJ; Fuster V Circulation; 2015 Jun; 131(24):2104-13. PubMed ID: 25882487 [TBL] [Abstract][Full Text] [Related]
10. Association of FGF-2 Concentrations with Atheroma Progression in Chronic Kidney Disease Patients. Bozic M; Betriu A; Bermudez-Lopez M; Ortiz A; Fernandez E; Valdivielso JM; Clin J Am Soc Nephrol; 2018 Apr; 13(4):577-584. PubMed ID: 29519952 [TBL] [Abstract][Full Text] [Related]
11. Subclinical cardiovascular disease assessment and its relationship with cardiovascular risk SCORE in a healthy adult population: A cross-sectional community-based study. Mitu O; Roca M; Floria M; Petris AO; Graur M; Mitu F Clin Investig Arterioscler; 2017; 29(3):111-119. PubMed ID: 28377040 [TBL] [Abstract][Full Text] [Related]
12. Randomised intervention study to assess the prevalence of subclinical vascular disease and hidden kidney disease and its impact on morbidity and mortality: The ILERVAS project. Betriu À; Farràs C; Abajo M; Martinez-Alonso M; Arroyo D; Barbé F; Buti M; Lecube A; Portero M; Purroy F; Torres G; Valdivielso JM; Fernández E Nefrologia; 2016; 36(4):389-96. PubMed ID: 27044887 [TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Personalized, Sex-Specific Prediction Algorithm of Severe Atheromatosis in Middle-Aged Asymptomatic Individuals: The ILERVAS Study. Bermúdez-López M; Martí-Antonio M; Castro-Boqué E; Bretones MDM; Farràs C; Torres G; Pamplona R; Lecube A; Mauricio D; Valdivielso JM; Fernández E Front Cardiovasc Med; 2022; 9():895917. PubMed ID: 35928938 [TBL] [Abstract][Full Text] [Related]
14. Subclinical Atherosclerosis Burden by 3D Ultrasound in Mid-Life: The PESA Study. López-Melgar B; Fernández-Friera L; Oliva B; García-Ruiz JM; Peñalvo JL; Gómez-Talavera S; Sánchez-González J; Mendiguren JM; Ibáñez B; Fernández-Ortiz A; Sanz J; Fuster V J Am Coll Cardiol; 2017 Jul; 70(3):301-313. PubMed ID: 28705310 [TBL] [Abstract][Full Text] [Related]
15. Observational multicenter study to evaluate the prevalence and prognosis of subclinical atheromatosis in a Spanish chronic kidney disease cohort: baseline data from the NEFRONA study. Arroyo D; Betriu A; Martinez-Alonso M; Vidal T; Valdivielso JM; Fernández E; BMC Nephrol; 2014 Oct; 15():168. PubMed ID: 25326683 [TBL] [Abstract][Full Text] [Related]
16. Usefulness of artery femoral ultrasound complementary to carotid exploration for the detection of subclinical atheromatosis in patients with human immunodeficiency virus infection. Verdejo-Muñoz G; Gálvez-Barrón C; Gamarra-Calvo S; Sanjoaquin Conde I; Catena A; Blanco Ramos JR Med Clin (Barc); 2023 May; 160(10):443-446. PubMed ID: 36759302 [TBL] [Abstract][Full Text] [Related]
17. Rheumatoid arthritis is sufficient to cause atheromatosis but not arterial stiffness or hypertrophy in the absence of classical cardiovascular risk factors. Arida A; Zampeli E; Konstantonis G; Fragiadaki K; Kitas GD; Protogerou AD; Sfikakis PP Clin Rheumatol; 2015 May; 34(5):853-9. PubMed ID: 25754335 [TBL] [Abstract][Full Text] [Related]